AAAAAA
Results: 26-50/93
Authors:
LISSONI P
PITTALIS S
ARDIZZOIA A
BRIVIO F
BARNI S
TANCINI G
PELIZZONI F
MAESTRONI GJM
ZUBELEWICZ B
BRACZKOWSKI R
Citation: P. Lissoni et al., PREVENTION OF CYTOKINE-INDUCED HYPOTENSION IN CANCER-PATIENTS BY THE PINEAL HORMONE MELATONIN, Supportive care in cancer, 4(4), 1996, pp. 313-316
Authors:
LISSONI P
BRIVIO O
BRIVIO F
BARNI S
TANCINI G
CRIPPA D
MEREGALLI S
Citation: P. Lissoni et al., ADJUVANT THERAPY WITH THE PINEAL HORMONE MELATONIN IN PATIENTS WITH LYMPH-NODE RELAPSE DUE TO MALIGNANT-MELANOMA, Journal of pineal research, 21(4), 1996, pp. 239-242
Authors:
LISSONI P
ROVELLI F
GIANI L
FUMAGALLI L
MEREGALLI S
COMI G
MERLINI D
Citation: P. Lissoni et al., CORRELATION BETWEEN IL-12 AND IL-2 BLOOD-LEVELS IN THE METASTATIC NEOPLASTIC DISEASE - A POSSIBLE INHIBITORY FEEDBACK-SYSTEM REGULATING THEIR SECRETION, Journal of biological regulators and homeostatic agents, 10(4), 1996, pp. 92-94
Authors:
DIFELICE G
FUMAGALLI L
MAJORCA F
BARNI S
ARDIZZOIA A
TANCINI G
LISSONI P
Citation: G. Difelice et al., REACTIVATION OF A NORMAL ENDOGENOUS SECRETION OF INTERLEUKIN-2 IN METASTATIC CANCER-PATIENTS BY A CHRONIC SUBCUTANEOUS INJECTION OF INTERLEUKIN-2, Journal of biological regulators and homeostatic agents, 10(4), 1996, pp. 98-99
Authors:
LISSONI P
BRIVIO F
PITTALIS S
ROVELLI F
RESCALDANI R
PEREGO MS
GRASSI MG
BARNI S
TANCINI G
MAJORCA F
FUMAGALLI L
Citation: P. Lissoni et al., CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS, Journal of biological regulators and homeostatic agents, 10(2-3), 1996, pp. 60-62
IMMUNOMODULATORY PROPERTIES OF A PINEAL INDOLE HORMONE OTHER THAN MELATONIN, THE 5-METHOXYTRYPTOPHOL
Authors:
LISSONI P
PITTALIS S
ROVELLI F
ZECCHI S
CASATI M
TREMOLADA M
PELIZZONI F
Citation: P. Lissoni et al., IMMUNOMODULATORY PROPERTIES OF A PINEAL INDOLE HORMONE OTHER THAN MELATONIN, THE 5-METHOXYTRYPTOPHOL, Journal of biological regulators and homeostatic agents, 10(1), 1996, pp. 27-30
Authors:
BARNI S
LISSONI P
TANCINI G
ARDIZZOIA A
CAZZANIGA M
Citation: S. Barni et al., EFFECTS OF ONE-YEAR ADJUVANT TREATMENT WITH TAMOXIFEN ON BONE-MINERALDENSITY IN POSTMENOPAUSAL BREAST-CANCER WOMEN, Tumori, 82(1), 1996, pp. 65-67
Authors:
LISSONI P
ARDIZZOIA A
BARNI S
PITTALIS S
ROSSINI F
PORTA A
TANCINI G
Citation: P. Lissoni et al., CHARACTERIZATION OF CANCER-RELATED DISSEMINATED INTRAVASCULAR COAGULATION IN RELATION TO TUMOR-NECROSIS-FACTOR-ALPHA BLOOD-CONCENTRATIONS -POSSIBLE THERAPEUTIC ROLE OF PENTOXIFYLLINE, Tumori, 82(1), 1996, pp. 78-80
Authors:
LISSONI P
FUMAGALLI L
BARNI S
DIFELICE G
ARDIZZOIA A
MAIORCA F
TANCINI G
Citation: P. Lissoni et al., BIOLOGICAL SIGNIFICANCE OF INTERLEUKIN-6 SECRETION ON CANCER-IMMUNOTHERAPY WITH INTERLEUKIN-2, International journal of immunotherapy, 12(3-4), 1996, pp. 49-52
Authors:
BRIVIO F
LISSONI P
ALDERI G
BARNI S
LAVORATO F
FUMAGALLI L
Citation: F. Brivio et al., PREOPERATIVE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY MAY PROLONG THESURVIVAL-TIME IN ADVANCED COLORECTAL-CANCER PATIENTS, Oncology, 53(4), 1996, pp. 263-268
Authors:
LISSONI P
MEREGALLI S
NOSETTO L
BARNI S
TANCINI G
FOSSATI V
MAESTRONI G
Citation: P. Lissoni et al., INCREASED SURVIVAL-TIME IN BRAIN GLIOBLASTOMAS BY A RADIONEUROENDOCRINE STRATEGY WITH RADIOTHERAPY PLUS MELATONIN COMPARED TO RADIOTHERAPY ALONE, Oncology, 53(1), 1996, pp. 43-46
Authors:
LISSONI P
PAOLOROSSI F
TANCINI G
ARDIZZOIA A
BARNI S
BRIVIO F
MAESTRONI GJM
CHILELLI M
Citation: P. Lissoni et al., A PHASE-II STUDY OF TAMOXIFEN PLUS MELATONIN IN METASTATIC SOLID TUMOR PATIENTS, British Journal of Cancer, 74(9), 1996, pp. 1466-1468
Authors:
LISSONI P
ARDIZZOIA A
BARNI S
BRIVIO F
TISI E
ROVELLI F
TANCINI G
MAESTRONI G
FUMAGALLI L
Citation: P. Lissoni et al., EFFICACY AND TOLERABILITY OF CANCER NEUROIMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEAL HORMONE MELATONIN - A PROGRESS REPORT OF 200 PATIENTS WITH ADVANCED SOLID NEOPLASMS, Oncology Reports, 2(6), 1995, pp. 1063-1068
Authors:
LISSONI P
ARDIZZOIA A
BARNI S
PAOLOROSSI F
TANCINI G
MEREGALLI S
ESPOSTI D
ZUBELEWICZ B
BRACZOWSKI R
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF TAMOXIFEN ALONE VERSUS TAMOXIFEN PLUS MELATONININ ESTROGEN RECEPTOR-NEGATIVE HEAVILY PRETREATED METASTATIC BREAST-CANCER PATIENTS, Oncology Reports, 2(5), 1995, pp. 871-873
Authors:
BRIVIO F
LISSONI P
FUMAGALLI L
BRIVIO O
LAVORATO F
RESCALDANI R
CONTI A
ROSELLI MG
MAESTRONI G
BARNI S
Citation: F. Brivio et al., PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA, Oncology Reports, 2(4), 1995, pp. 597-599
Authors:
LISSONI P
BARNI S
TANCINI G
ADIZZOIA A
PAOLOROSSI F
Citation: P. Lissoni et al., TREATMENT OF INTERFERON-ALPHA 2A(IFN)-INDUCED THROMBOCYTOPENIA BY THEPINEAL NEUROHORMONE MELATONIN (MTL), European journal of cancer, 31A, 1995, pp. 583-583
Authors:
LISSONI P
BARNI S
FOSSATI V
ARDIZZOIA A
CAZZANIGA M
TANCINI G
FRIGERIO F
Citation: P. Lissoni et al., A RANDOMIZED STUDY OF NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN COMPARED TO SUPPORTIVE CARE ALONE IN PATIENTS WITH UNTREATABLE METASTATIC SOLID TUMOR, Supportive care in cancer, 3(3), 1995, pp. 194-197
Authors:
LISSONI P
BARNI S
TANCINI G
ARDIZZOIA A
TISI E
ANGELI M
RIZZI A
Citation: P. Lissoni et al., INTRACAVITARY THERAPY OF NEOPLASTIC EFFUSIONS WITH CYTOKINES - COMPARISON AMONG INTERFERON-ALPHA, INTERFERON-BETA AND INTERLEUKIN-2, Supportive care in cancer, 3(1), 1995, pp. 78-80
Authors:
LISSONI P
ROVELLI F
TISI E
BRIVIO F
ARDIZZOIA A
BARNI S
TANCINI G
SAUDELLI M
CESANA E
VIGANO MG
Citation: P. Lissoni et al., RELATION BETWEEN MACROPHAGE AND T-HELPER-2 LYMPHOCYTE FUNCTIONS IN HUMAN NEOPLASMS - NEOPTERIN, INTERLEUKIN-10 AND INTERLEUKIN-6 BLOOD-LEVELS IN EARLY OR ADVANCED SOLID TURNERS, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 146-149
Authors:
LISSONI P
VIGORE L
RESCALDANI R
ROVELLI F
BRIVIO F
GIANI L
BARNI S
TANCINI G
ARDIZZOIA A
VIGANO MG
Citation: P. Lissoni et al., NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN AIDS PATIENTS WITH CD4 CELL NUMBER BELOW 200 MM(3) - A BIOLOGICAL PHASE-II STUDY/, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 155-158
Authors:
LISSONI P
BARNI S
BRIVIO F
ROSSINI F
FUMAGALLI L
TANCINI G
Citation: P. Lissoni et al., TREATMENT OF CANCER-RELATED THROMBOCYTOPENIA BY LOW-DOSE SUBCUTANEOUSINTERLEUKIN-2 PLUS THE PINEAL HORMONE MELATONIN - A BIOLOGICAL PHASE-II STUDY, Journal of biological regulators and homeostatic agents, 9(2), 1995, pp. 52-54
Authors:
LISSONI P
PITTALIS S
ROVELLI F
VIGORE L
ROSELLI MG
BRIVIO F
Citation: P. Lissoni et al., INTERLEUKIN-2, MELATONIN AND INTERLEUKIN-12 AS A POSSIBLE NEUROIMMUNECOMBINATION IN THE BIOTHERAPY OF CANCER, Journal of biological regulators and homeostatic agents, 9(2), 1995, pp. 63-66
Authors:
LISSONI P
BARNI S
ARDIZZOIA A
SCARDINO E
TANCINI G
VIGANO MG
Citation: P. Lissoni et al., CORRELATION BETWEEN PRETREATMENT SERUM LEVELS OF NEOPTERIN AND RESPONSE TO INTERLEUKIN-2 IMMUNOTHERAPY IN CANCER-PATIENTS, Journal of biological regulators and homeostatic agents, 9(1), 1995, pp. 21-23
Authors:
LISSONI P
BRIVIO F
BRIVIO O
FUMAGALLI L
GRAMAZIO F
ROSSI M
EMANUELLI G
ALDERI G
LAVORATO F
Citation: P. Lissoni et al., IMMUNE EFFECTS OF PREOPERATIVE IMMUNOTHERAPY WITH HIGH-DOSE SUBCUTANEOUS INTERLEUKIN-2 VERSUS NEUROIMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 PLUS THE NEUROHORMONE MELATONIN IN GASTROINTESTINAL-TRACT TUMOR PATIENTS, Journal of biological regulators and homeostatic agents, 9(1), 1995, pp. 31-33
Authors:
ROVELLI F
BARNI S
TANCINI G
ARDIZZOIA A
LISSONI P
Citation: F. Rovelli et al., ENDOCRINE EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN CANCER-PATIENTS, Tumori, 81(6), 1995, pp. 438-439